Plunkett Research Online: Alpine Immune Sciences Inc

ALPINE IMMUNE SCIENCES INC (ALPN:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Alpine Immune Sciences Inc is a clinical-stage immunotherapy company. The company is focused on developing innovative treatments for autoimmune and inflammatory diseases. To improve the lives of patients, the group aims to create multifunctional immunotherapies through unique protein engineering tec.....



Alpine Immune Sciences Inc
Ticker: ALPN
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 206 788-4545
Fax:
Address: 188 East Blaine Street
Suite 200
Seattle, WA 98102 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
Contacts Description
Mitchell GoldCEO/Chairman of the Board/Director
Paul RickeyCFO/Chief Accounting Officer/Secretary/Senior VP
See More
Alpine Immune Sciences Inc is a clinical-stage immunotherapy company. The company is focused on developing innovative treatments for autoimmune and inflammatory diseases. To improve the lives of patients, the group aims to create multifunctional immunotherapies through unique protein engineering tec.....See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202220212020201920182017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: